NHS priorities

Whether it’s to prepare for the next Quality Payments Scheme deadline, or to increase your confidence in helping people with a learning disability, this section provides topic-specific pages that link to current NHS priorities. This section will support you in keeping your knowledge and skills up to date in order to provide high-quality pharmacy services and be service-ready.

Clinical pharmacy

Our clinical portfolio is expanding on a frequent basis, helping you to advance your knowledge and skills and deliver medicines optimisation in practice for all sectors of pharmacy. From two new focal points a year to our small group learning for hospital pharmacists – Optimise – this section focuses on clinical pharmacy, diseases and therapeutics.

Public health

The public health agenda is embedded in pharmacy, yet topics such as emergency contraception or stop smoking support are as prevalent as ever. As well as our public health workshops, use this section to access a wide range of resources to assure and maintain your competence, all underpinned by the Declaration of Competence system.

Liver

Falsequestion-signTrue
FalselaptopTrue

The aim of this e-learning programme is to provide learners with a basic awareness of important blood tests and how to interpret them in order to support the diagnosis and management of patients. Section 1 covers full blood count, inflammatory markers and coagulation.

There are three sections which make up this learning programme. To access the other sections, select the links below:

Section 2 covers chronic disease markers, urea and electrolytes and liver function tests.

Section 3 covers thyroid function tests, bone function tests and therapeutic drug monitoring.

Please note: this e-learning programme has been developed and provided by the Welsh Centre for Pharmacy Professional Education (WCPPE). Users should recognise that this programme may refer to Welsh policies and organisations. CPPE does not maintain control over the accuracy and currency of this programme.


3h:00m (for events this includes pre and post event learning)


Learning Objectives:

On completion of all three sections of this learning programme you should be able to:
  • explain the importance of laboratory testing in diagnostics and patient monitoring
  • demonstrate understanding of the theoretical basis of and varied approach to investigation and monitoring of interventions
  • advise on the appropriate treatment of patients with abnormal test results
  • recognise the drugs that require therapeutic drug monitoring.
FalselaptopTrue

Learn how to recognise abnormal liver function test results, how to explain this physiologically and the appropriate action to take when abnormal results are due to a medicine.


1h:00m (for events this includes pre and post event learning)

FalselaptopTrue

The aim of this e-learning programme is to provide learners with a basic awareness of important blood tests and how to interpret them in order to support the diagnosis and management of patients. Section 2 covers chronic disease markers, urea and electrolytes and liver function tests.

There are three sections which make up this learning programme. To access the other sections, select the links below:

Section 1 covers full blood count, inflammatory markers and coagulation.

Section 3 covers thyroid function tests, bone function tests and therapeutic drug monitoring.

We are aware of problems on two pages in this programme and are working with WCPPE to resolve the issues. Please note that in the section on diabetes, the information on the oral glucose tolerance test (OGTT) refers to the use of Lucozade®. Changes to the formulation of this product mean that it is no longer used in the OGTT.

Please note: this e-learning programme has been developed and provided by the Welsh Centre for Pharmacy Professional Education (WCPPE). Users should recognise that this programme may refer to Welsh policies and organisations. CPPE does not maintain control over the accuracy and currency of this programme.


3h:00m (for events this includes pre and post event learning)


Learning Objectives:

On completion of all three sections of this learning programme you should be able to:
  • explain the importance of laboratory testing in diagnostics and patient monitoring
  • demonstrate understanding of the theoretical basis of and varied approach to investigation and monitoring of interventions
  • advise on the appropriate treatment of patients with abnormal test results
  • recognise the drugs that require therapeutic drug monitoring.
FalselaptopTrue

The aim of this e-learning programme is to provide learners with a basic awareness of important blood tests and how to interpret them in order to support the diagnosis and management of patients. Section 3 covers thyroid function tests, bone function tests and therapeutic drug monitoring.

There are three sections which make up this learning programme. To access the other sections, select the links below:

Section 1 covers full blood count, inflammatory markers and coagulation.

Section 2 covers chronic disease markers, urea and electrolytes and liver function tests.

Please note: this e-learning programme has been developed and provided by the Welsh Centre for Pharmacy Professional Education (WCPPE). Users should recognise that this programme may refer to Welsh policies and organisations. CPPE does not maintain control over the accuracy and currency of this programme.


3h:00m (for events this includes pre and post event learning)


Learning Objectives:

On completion of all three sections of this learning programme you should be able to:
  • explain the importance of laboratory testing in diagnostics and patient monitoring
  • demonstrate understanding of the theoretical basis of and varied approach to investigation and monitoring of interventions
  • advise on the appropriate treatment of patients with abnormal test results
  • recognise the drugs that require therapeutic drug monitoring.
Falsenew-windowTrue
external resource

Medscape MELD score for end-stage liver disease (not suitable for patients under the age of 12)

Falsenew-windowTrue
Falsenew-windowTrue
Falsenew-windowTrue
external resource

NICE NG49 Non-alcoholic fatty liver disease (NAFLD): assessment and management

Falsenew-windowTrue
Falsenew-windowTrue
external resource

NICE CG100 Alcohol-use disorders: diagnosis and management of physical complications

Falsenew-windowTrue
external resource

NICE Bites is a monthly prescribing bulletin from the North West Medicines Information Centre which summarises key prescribing points from NICE guidance.

Falsenew-windowTrue
external resource

Early palliative interventions, including reviewing regular medicines and managing common symptoms, enables patients to remain comfortable during end-of-life care.

Please help us improve our website by letting us know what you like and reporting anything that isn't quite right.